Indian Pharma
Best time to invest in pharma, medical device sector: Sadananda Gowda
New launches in key categories to trigger AstraZeneca Pharma's growth
RIL picks majority stake in Netmeds: How it became 'India ki pharmacy'
Chemist body warns against Amazon's entry into online pharmacy space
China crisis, India scouting for APIs a shot in arm for sick pharma PSU

Covid-19 crisis: Indian drug companies yet to get nod to market remdesivir
Trump's focus on local drugs not immediate concern: Indian pharma industry
Lincoln Pharma plans to foray into regulated markets, upgrades facility
India scores better than US in regulatory action by USFDA in 2019
Prolonged coronavirus outbreak in China could hurt Indian pharma sector

Indian pharma cos with bigger US presence face more FDA scrutiny: Analysts
Indian pharma firms see fall in rate of final product approvals from USFDA
Indian drug firms' growth slowed in 2017 on slow approvals, MNCs' caught up
Indian pharma should look beyond generics
Indian pharma lags on digital adoption: EY
Indian pharma poised for US acquisitions
Indian drug firms' R&D spending rises as growth slows in US, domestic mkts
Indian pharma's long road to redemption
Drugmakers need time to meet global standards: Indian Pharma Association
Rising rupee another risk for Indian pharma